Crampes et fasciculations : est-ce une sclérose latérale amyotrophique ? [Cramps and fasciculations: is it amyotrophic lateral sclerosis?]
Fiche du document
27 avril 2022
- doi: 10.53738/REVMED.2022.18.779.790
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2022.18.779.790
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35481502
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_80B09BBBF3EE5
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Citer ce document
A. Hübers et al., « Crampes et fasciculations : est-ce une sclérose latérale amyotrophique ? [Cramps and fasciculations: is it amyotrophic lateral sclerosis?] », Serveur académique Lausannois, ID : 10.53738/REVMED.2022.18.779.790
Métriques
Partage / Export
Résumé
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease of the adult age. It is an aggressive condition with a mean disease duration of only 3 to 5 years, characterized by progressive weakness and atrophy of limb, bulbar, and respiratory muscles. In general, death is caused by chronic hypoventilation due to respiratory insufficiency. No causal treatment is known today, but the two therapeutic agents authorized in Switzerland for the treatment of ALS can slow disease progression significantly. Other important therapeutic strategies include invasive/non-invasive ventilation, pain therapy, as well as physio-, ergo- and speech therapy on a regular basis.